Immulite® 2000 Br-Ma
System, Test, Immunological, Antigen, Tumor. 510(k) K233946, from Siemens Healthcare Diagnostics Products, Ltd. (Llanberis, GB). Product code MOI, class 2.
As of Nov 19, 2026, K233946 is an FDA 510(k) held by Siemens Healthcare Diagnostics Products, Ltd., substantially equivalent on Mar 13, 2024 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
For in vitro diagnostic use with the IMMULITE 2000 Systems Analyzers - for the quantitative measurement of CA15-3 antigen in human serum and plasma, as an aid in the detection of recurrence in previously treated stage II and stage III breast cancer patients, and in the management of metastatic breast cancer patients by monitoring disease progression or response to treatment.
- Immulite Br-Ma, Model #Lkbr; Immulite 2000 Br-Ma, Model #L2KBRK013984 · Diagnostic Products Corp. · Mar 28, 2002
- Access BR MonitorK240403 · Beckman Coulter, Inc. · May 9, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 14, 2023
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files